A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)

< b > Condition < /b > :   Ulcerative Colitis < br/ > < b > Interventions < /b > :   Drug: LT-02;   Drug: LT-02 Placebo < br/ > < b > Sponsors < /b > :   Prometheus Laboratories;   Nestlè Health Science;   INC Research < br/ > < b > Recruiting < /b > - verified July 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials